176 related articles for article (PubMed ID: 30447498)
1. Serum perfluoroalkyl substances (PFAS) and risk of asthma and various allergies in adolescents. The Tromsø study Fit Futures in Northern Norway.
Averina M; Brox J; Huber S; Furberg AS; Sørensen M
Environ Res; 2019 Feb; 169():114-121. PubMed ID: 30447498
[TBL] [Abstract][Full Text] [Related]
2. Exposure to perfluoroalkyl substances (PFAS) and dyslipidemia, hypertension and obesity in adolescents. The Fit Futures study.
Averina M; Brox J; Huber S; Furberg AS
Environ Res; 2021 Apr; 195():110740. PubMed ID: 33460636
[TBL] [Abstract][Full Text] [Related]
3. Perfluoroalkyl substances in adolescents in northern Norway: Lifestyle and dietary predictors. The Tromsø study, Fit Futures 1.
Averina M; Brox J; Huber S; Furberg AS
Environ Int; 2018 May; 114():123-130. PubMed ID: 29500988
[TBL] [Abstract][Full Text] [Related]
4. Perfluoroalkyl substances, airways infections, allergy and asthma related health outcomes - implications of gender, exposure period and study design.
Kvalem HE; Nygaard UC; Lødrup Carlsen KC; Carlsen KH; Haug LS; Granum B
Environ Int; 2020 Jan; 134():105259. PubMed ID: 31733527
[TBL] [Abstract][Full Text] [Related]
5. Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian Mother and Child (MoBa) cohort.
Impinen A; Longnecker MP; Nygaard UC; London SJ; Ferguson KK; Haug LS; Granum B
Environ Int; 2019 Mar; 124():462-472. PubMed ID: 30684804
[TBL] [Abstract][Full Text] [Related]
6. Impact of PFAS exposure on prevalence of immune-mediated diseases in adults in the Czech Republic.
Rudzanova B; Vlaanderen J; Kalina J; Piler P; Zvonar M; Klanova J; Blaha L; Adamovsky O
Environ Res; 2023 Jul; 229():115969. PubMed ID: 37116680
[TBL] [Abstract][Full Text] [Related]
7. Prenatal exposure to perfluoralkyl substances (PFASs) associated with respiratory tract infections but not allergy- and asthma-related health outcomes in childhood.
Impinen A; Nygaard UC; Lødrup Carlsen KC; Mowinckel P; Carlsen KH; Haug LS; Granum B
Environ Res; 2018 Jan; 160():518-523. PubMed ID: 29106950
[TBL] [Abstract][Full Text] [Related]
8. Association between prenatal exposure to perfluoroalkyl substances and asthma in 5-year-old children in the Odense Child Cohort.
Beck IH; Timmermann CAG; Nielsen F; Schoeters G; Jøhnk C; Kyhl HB; Høst A; Jensen TK
Environ Health; 2019 Nov; 18(1):97. PubMed ID: 31730470
[TBL] [Abstract][Full Text] [Related]
9. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
[TBL] [Abstract][Full Text] [Related]
10. Perfluoroalkyl substance exposure and urine CC16 levels among asthmatics: A case-control study of children.
Zhou Y; Bao WW; Qian ZM; Dee Geiger S; Parrish KL; Yang BY; Lee YL; Dong GH
Environ Res; 2017 Nov; 159():158-163. PubMed ID: 28802206
[TBL] [Abstract][Full Text] [Related]
11. Association of perfluoroalkyl substances exposure with impaired lung function in children.
Qin XD; Qian ZM; Dharmage SC; Perret J; Geiger SD; Rigdon SE; Howard S; Zeng XW; Hu LW; Yang BY; Zhou Y; Li M; Xu SL; Bao WW; Zhang YZ; Yuan P; Wang J; Zhang C; Tian YP; Nian M; Xiao X; Chen W; Lee YL; Dong GH
Environ Res; 2017 May; 155():15-21. PubMed ID: 28171771
[TBL] [Abstract][Full Text] [Related]
12. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.
Granum B; Haug LS; Namork E; Stølevik SB; Thomsen C; Aaberge IS; van Loveren H; Løvik M; Nygaard UC
J Immunotoxicol; 2013; 10(4):373-9. PubMed ID: 23350954
[TBL] [Abstract][Full Text] [Related]
13. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination.
Timmermann CA; Budtz-Jørgensen E; Jensen TK; Osuna CE; Petersen MS; Steuerwald U; Nielsen F; Poulsen LK; Weihe P; Grandjean P
J Immunotoxicol; 2017 Dec; 14(1):39-49. PubMed ID: 28091126
[TBL] [Abstract][Full Text] [Related]
14. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
[TBL] [Abstract][Full Text] [Related]
15. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health.
Ait Bamai Y; Goudarzi H; Araki A; Okada E; Kashino I; Miyashita C; Kishi R
Environ Int; 2020 Oct; 143():105979. PubMed ID: 32717646
[TBL] [Abstract][Full Text] [Related]
16. Association of polyfluoroalkyl chemical exposure with serum lipids in children.
Zeng XW; Qian Z; Emo B; Vaughn M; Bao J; Qin XD; Zhu Y; Li J; Lee YL; Dong GH
Sci Total Environ; 2015 Apr; 512-513():364-370. PubMed ID: 25638651
[TBL] [Abstract][Full Text] [Related]
17. Exposure to Perfluoroalkyl Substances and Metabolic Outcomes in Pregnant Women: Evidence from the Spanish INMA Birth Cohorts.
Matilla-Santander N; Valvi D; Lopez-Espinosa MJ; Manzano-Salgado CB; Ballester F; Ibarluzea J; Santa-Marina L; Schettgen T; Guxens M; Sunyer J; Vrijheid M
Environ Health Perspect; 2017 Nov; 125(11):117004. PubMed ID: 29135438
[TBL] [Abstract][Full Text] [Related]
18. Serum perfluoroalkyl substances and breast cancer risk in Japanese women: A case-control study.
Itoh H; Harada KH; Kasuga Y; Yokoyama S; Onuma H; Nishimura H; Kusama R; Yokoyama K; Zhu J; Harada Sassa M; Tsugane S; Iwasaki M
Sci Total Environ; 2021 Dec; 800():149316. PubMed ID: 34392213
[TBL] [Abstract][Full Text] [Related]
19. Assessing the relationship between perfluoroalkyl substances, thyroid hormones and binding proteins in pregnant women; a longitudinal mixed effects approach.
Berg V; Nøst TH; Hansen S; Elverland A; Veyhe AS; Jorde R; Odland JØ; Sandanger TM
Environ Int; 2015 Apr; 77():63-9. PubMed ID: 25647630
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
